Work

Free interleukin-18 is elevated in CD22 CAR T-cell–associated hemophagocytic lymphohistiocytosis–like toxicities

Year: 2023

Type: article

Source: Blood Advances

DOI: 10.1182/bloodadvances.2023010708

Authors: Joseph M. Rocco, Jon Inglefield, Bonnie Yates, Daniel A. Lichtenstein, Yanyu Wang, Laurence Goffin, Djordje Filipovic, Eduardo J. Schiffrin, Nirali N. Shah

Institutions: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Frederick National Laboratory for Cancer Research, National Cancer Institute, Leidos Biomedical Research Inc. (United States), Center for Cancer Research, Cincinnati Children's Hospital Medical Center, University of Cincinnati, École Polytechnique Fédérale de Lausanne

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,000

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Clinical Center

Award: Development of Novel Approaches to Optimize CAR T-cell Therapies for B-cell Malignancies

OpenAlex ID: W4382632635

FWCI: 2.875

Cites: 26

Cited by: 28

Related to: 10